Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Hinton proposes FDA-style pre-approval for AI models before release

AI summary

Geoffrey Hinton proposed on the Smart Girl Dumb Questions podcast that AI companies should have to prove a product's safety to regulators before it is released. Drawing on the pharmaceutical industry, he said a new drug cannot go to market without convincing the FDA, a process he estimated requires roughly a billion dollars of work, and argued AI should face at least the same requirement. A Huxiu commentary also rounds up his related remarks from a September 16 closed-door Capitol Hill briefing and an October 6 interview: developers would supply verifiable safety evidence to third-party and official reviewers, the window to build a regulatory system is only about one to two years, RLHF is merely cosmetic, and recursive self-improvement is a source of risk — while noting some of his judgments are his own speculation.

In-depth insight

Under Hinton's proposal, developers would have to prove a model is safe to regulators before release, inverting the "launch first, fix later" approach that Huxiu describes as current practice.

“AI 教父”辛顿提议 AI 行业建立 FDA 式审批机制:模型推出前需通过安全审核 - IT之家

首页

IT圈

最会买

设置

  • 日夜间 随系统 浅色 深色
  • 主题色 黑色

#Geoffrey Hinton#FDA#OpenAI#GPT-6.1 Astra#Anthropic#Hugging Face#Smart Girl Dumb Questions

Original · 3 min readRead the original
Group chat

No comments yet. Start the conversation.